Migraine is ranked as the third most prevalent disorder, the eight most burdensome disease and the seventh cause of disability worldwide [1]. Although its prevalence decreases after the age of 60, it still affects 7% of women and 3% of men over 65. A successful treatment of a late-life migraine is particularly important due to the association with increased risk of ischemic stroke, white matter lesions and other transient neurological phenomena (migraine accompaniments) responsive to prophylactic medications
How do you choose the appropriate migraine pharmacotherapy for an elderly person? / Curto, Martina; Capi, Matilde; Martelletti, Paolo; Lionetto, Luana. - In: EXPERT OPINION ON PHARMACOTHERAPY. - ISSN 1465-6566. - 20:1(2019), pp. 1-3. [10.1080/14656566.2018.1543660]
How do you choose the appropriate migraine pharmacotherapy for an elderly person?
Curto, Martina
;Capi, Matilde;Martelletti, Paolo;
2019
Abstract
Migraine is ranked as the third most prevalent disorder, the eight most burdensome disease and the seventh cause of disability worldwide [1]. Although its prevalence decreases after the age of 60, it still affects 7% of women and 3% of men over 65. A successful treatment of a late-life migraine is particularly important due to the association with increased risk of ischemic stroke, white matter lesions and other transient neurological phenomena (migraine accompaniments) responsive to prophylactic medications| File | Dimensione | Formato | |
|---|---|---|---|
|
Curto_How-do-you_2019 .pdf
solo gestori archivio
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
659.17 kB
Formato
Adobe PDF
|
659.17 kB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
